局部麻醉劑市場：依藥物類型、給藥途徑及地區分類

Local Anesthesia Drugs Market, By Drug Type, By Mode Of Administration, By Geography

出版日期: 2026年03月17日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年局部麻醉劑市場規模估計為53億美元，預計2033年將達87億美元。預計2026年至2033年，該市場將以4.1%的複合年成長率成長。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	53億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	4.10%	預計金額（2033 年）	87億美元

局部麻醉是一種使用局部麻醉劑來麻痺身體特定部位的治療方法。它是一種鎮痛方式，用於在小型手術中麻痺易痛的小區域。使用長效局部麻醉劑可以延長神經阻斷麻醉的效果。局部麻醉劑用於治療疼痛症狀、預防手術或手術過程中的疼痛，或緩解術後疼痛。與全身麻醉劑相比，局部麻醉劑使用起來更安全，副作用也更少。

市場動態

手術數量的增加以及術後鎮痛中局部麻醉劑的廣泛應用，正在推動局部局部麻醉劑的成長，預計這一趨勢將在預測期內持續。例如，根據美國整形外科麻醉劑協會的數據，2020年美國共進行了超過680萬例重組手術、1,320萬例微創美容手術和約230萬例美容手術。

此外，2021 年 5 月，美國食品藥物管理局(FDA)核准了首個緩釋雙效局部麻醉劑，即Bupivacaine和美洛昔康的組合，用於疼痛管理。

本報告的主要特點

本報告指出了各個細分市場的潛在商機，並概述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
本節根據以下參數介紹全球局部麻醉劑市場的主要企業概況：公司概況、產品系列、主要亮點、財務績效和策略。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
《全球局部麻醉劑市場》報告面向該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過分析全球局部麻醉劑市場中使用的各種策略矩陣來促進決策。

Report Coverage	Report Details
Base Year:	2025	Market Size in 2026:	USD 5.3 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	4.10%	2033 Value Projection:	USD 8.7 Bn

Local anaesthesia involves numbing an area of the body using a type of medicine called a local anaesthetic. It is a type of pain control used during minor procedures to numb small area where the pain is likely to occur. The use of long-acting local anesthetic prolongs the anesthetic effect of regional anesthesia. Local anesthesia drugs can be used to treat painful conditions, prevent pain during a procedure or operation, or relieve pain after surgery. Local anesthetics are much safer to use, but have fewer side effects compared to general anesthetics.

Market Dynamics

Increasing use of local anesthesia drugs across the globe due to increase in number of surgeries and increasing use of local anesthetic for post-operative pain is expected to augment the growth of the global local anesthesia drugs market over the forecast period. For instance, according to the American Society of Plastic Surgeons, in 2020, over 6.8 million reconstructive procedures, 13.2 million cosmetic minimally invasive procedures, and around 2.3 million cosmetic surgical procedures were performed in the United States.

Moreover, in May 2021, the Food and Drug Administration (FDA) approved the first extended-release dual acting local anesthetic of bupivacaine and meloxicam for pain management.

Key features of the study

This report provides in-depth analysis of the global local anesthesia drugs market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global local anesthesia drugs market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global local anesthesia drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global local anesthesia drugs market.

Market Segmentation

By Drug Type
- Bupivacaine
- Lidocaine
- Benzocaine
- Ropivacaine
- Prilocaine
- Chloroprocaine
- Others
By Mode Of Administration
- Injectable
- Surface Anesthetic
By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Septodont
- Pfizer Inc.
- Pacira BioSciences, Inc.
- Braun Melsulgen AG
- Glenmark Pharmaceutical Ltd.
- Fresenius SE & Co. KgaA
- Hikma Pharmaceuticals PLC
- Teva Pharmaceutical Industries Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Nasal Drug Delivery Mode, By Drug Type
- Market Nasal Drug Delivery Mode, By Mode of Administration
- Market Nasal Drug Delivery Mode, By Geography
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increase in number of surgeries worldwide
- Side effects of anesthetic drugs
- Growing use of local anesthetic drugs
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Local Anesthesia Drugs Market, By Drug Type, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Bupivacaine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Lidocaine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Benzocaine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Ropivacaine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Prilocaine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Chloroprocaine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Local Anesthesia Drugs Market, By Mode of Administration, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Surface Anesthetic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Local Anesthesia Drugs Market, By Geography, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
- Countries
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
- Countries
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
South Africa
North Africa
Central Africa

7. Competitive Landscape

Septodont
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pacira BioSciences, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Braun Melsulgen AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Glenmark Pharmaceutical Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fresenius SE & Co. KgaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hikma Pharmaceuticals PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views